Practo and Lybrate don't mess with cancer. But Onco's panel of specialists is raring to take it on, never mind where the patient is.
The Accel Partners-backed startup is trying to tap the vertical cancer-care space left unattended by other health-tech upstarts. It's game plan: master two critical variables — time and location.
Priyanka Salve
26 Nov 2018 7 Mins Read	1 comments
People queuing outside the All India Institute of Medical Sciences, New Delhi. For life-threatening illnesses like cancer, treatment at government hospitals could mean waiting months.
When Amit Jotwani, a practising oncologist, co-founded Onco.com in 2016 with Rashie Jain, they had spotted a niche left vacant by the Practos and Lybrates of the world. While Tencent-backed Practo is synonymous with doctor-listing and appointment-booking services (it now offers e-consultations as well), Lybrate has taken the community-based approach, where people can pose questions to medical professionals and
[[/invite.data.inviteByName]] [[/invite.loggedin]] [[/invite.invited]] will rely on advice from that one doctor he knows for all ailments," says Jain. "That needs to change." The solution, she adds, lies in a network play that will give the best advice to patients and also increase price transparency. "We have a first-mover advantage, having built a strong network," she says. ( Graphics by Ankita Mehrotra)
will rely on advice from that one doctor he knows for all ailments," says Jain. "That needs to change." The solution, she adds, lies in a network play that will give the best advice to patients and also increase price transparency. "We have a first-mover advantage, having built a strong network," she says. ( Graphics by Ankita Mehrotra)
CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY
Lakshman Gowda T L	HCG Hospitals, Vice President